We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biogen Inc | NASDAQ:BIIB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.80 | -1.22% | 227.24 | 227.20 | 227.50 | 229.66 | 226.43 | 229.42 | 182,567 | 15:37:11 |
Delaware
|
0-19311
|
33-0112644
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
1.
|
Stockholders elected eleven nominees to the Board of Directors to serve for a one-year term extending until the 2019 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows:
|
Nominee
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
||||
Alexander J. Denner
|
|
157,681,261
|
|
|
9,664,386
|
|
|
576,090
|
|
|
14,573,630
|
|
Caroline D. Dorsa
|
|
157,434,403
|
|
|
9,677,268
|
|
|
810,066
|
|
|
14,573,630
|
|
Nancy L. Leaming
|
|
158,893,984
|
|
|
8,217,493
|
|
|
810,260
|
|
|
14,573,630
|
|
Richard C. Mulligan
|
|
159,714,555
|
|
|
7,630,683
|
|
|
576,499
|
|
|
14,573,630
|
|
Robert W. Pangia
|
|
155,816,805
|
|
|
11,325,013
|
|
|
779,919
|
|
|
14,573,630
|
|
Stelios Papadopoulos
|
|
153,686,995
|
|
|
12,454,094
|
|
|
1,780,648
|
|
|
14,573,630
|
|
Brian S. Posner
|
|
158,057,511
|
|
|
9,047,930
|
|
|
816,296
|
|
|
14,573,630
|
|
Eric K. Rowinsky
|
|
158,363,760
|
|
|
8,668,825
|
|
|
889,152
|
|
|
14,573,630
|
|
Lynn Schenk
|
|
156,698,182
|
|
|
10,413,299
|
|
|
810,256
|
|
|
14,573,630
|
|
Stephen A. Sherwin
|
|
159,567,535
|
|
|
7,533,951
|
|
|
820,251
|
|
|
14,573,630
|
|
Michel Vounatsos
|
|
158,958,201
|
|
|
8,143,565
|
|
|
819,971
|
|
|
14,573,630
|
|
2.
|
Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2018, with the votes cast as follows:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
180,175,118
|
|
1,979,549
|
|
340,700
|
|
-
|
3.
|
Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
158,785,398
|
|
7,670,851
|
|
1,465,488
|
|
14,573,630
|
4.
|
A stockholder proposal requesting certain proxy access bylaw amendments was not approved, with the votes cast as follows:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
47,675,995
|
|
118,395,156
|
|
1,850,586
|
|
14,573,630
|
5.
|
A stockholder proposal requesting a report on the extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements was not approved, with the votes cast as follows:
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-Votes
|
46,608,359
|
|
118,636,079
|
|
2,677,299
|
|
14,573,630
|
1 Year Biogen Chart |
1 Month Biogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions